Atlas Trials

Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).

Clinical trial NCT06603753 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06603753
Sponsor
alaa aboelhassan mohamed aboelhassan
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Hyperbilirubinemia, Neonatal
Start date
2025-01-01
Primary completion
2026-01-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.